Trevor enjoyed a long career with Fairfax Business Media writing on Australian equities for the AFR among other titles.
The company's slow release technology may have applications that are beneficial for the ageing population.
Crystal Mountain, generated revenues of $1.8 million in the seven month period.
Of 45 patients treated, 84.4% responded with a reduction in joint pain.
Stage I includes greenhouses for indoor cultivation and growth of medicinal cannabis.
The placement price of 2.1 cents represents a 9% discount to its recent trading range.
The group's strategic objective is to identify and in-license novel drug assets.
Medlab developed the nanoparticle medicine delivery system, Nanocelle.
REVA expects to expand its product portfolio by launching the thin strut Fantom Encore.